| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Through this arrangement, Cogent will initially launch its newly developed CBD lozenge on Aurora's Canadian medical cannabi...
EPA grants $6.2M to Hemp Building Institute to boost hempcrete use in construction, aligning with Biden's climate goals. Re...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has scheduled a conference call to discuss the results for its first quarter 2025...
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has been granted two licenses by the Federal In...
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rap...
